HIF1A and hepatocellular carcinoma: MiR-338-3p. Hypoxia being one of the main contributors to anti-tumor drug resistance in solid malignancies, hypoxia-inducible factor 1 (HIF-1) has been recognized as one of the key mediators of resistance to sorafenib in HCC.